Division of Infectious Diseases

The Weekly Corona with Dr. Raquel Lamarche

Dr. Raquel Lamarche is a PGY1 Internal Medicine/Pediatrics resident at UNMC, who will be summarizing updates about SARS-CoV-2 and hopefully make information easier to digest, with additional outlines of implications for graduate medical education. This week Dr. Lamarche discusses a pediatric Infectious Diseases primer. You can follow Dr. Lamarche on Twitter @LamarcheRaquel.

The Weekly Corona with Dr. Raquel Lamarche

Dr. Raquel Lamarche is a PGY1 Internal Medicine/Pediatrics resident at UNMC, who will be summarizing updates about SARS-CoV-2 and hopefully make information easier to digest, with additional outlines of implications for graduate medical education. This week Dr. Lamarche discusses “Wellness in the time of COVID-19”. You can follow Dr. Lamarche on Twitter @LamarcheRaquel.

The Weekly Corona with Dr. Raquel Lamarche

Dr. Raquel Lamarche is a PGY1 Internal Medicine/Pediatrics resident at UNMC, who will be summarizing updates about SARS-CoV-2 and hopefully make information easier to digest, with additional outlines of implications for graduate medical education. This week Dr. Lamarche discusses “Innovation in the time of COVID-19: No idea is too small”. You can follow Dr. Lamarche on Twitter @LamarcheRaquel.

Ongoing Debate on the Treatment of Staphylococcus aureus Bacteremia

Dr. Andre Kalil, our Director of Transplant Infectious Diseases, recently co-authored a reply to Geriak et al.: “Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.” Debate around the findings of this article was recently featured by Dr. Razan El Ramahi in the IDSA ID journal club and on this blog. In their reply to… Continue Reading

A critical examination of the controversial study behind hydroxychloroquine and azithromycin for COVID-19

On March 20th, the International Journal of Antimicrobial Agents published Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial by Gautret et al.  The president of the United States tweeted about the article the very next day, and on March 28th the FDA announced an emergency use authorization to allow the distribution of hydroxychloroquine and chloroquine from national stockpiles… Continue Reading

Meet our newest blog contributor: Dr. Nicolás Cortés-Penfield

Dr. Nicolás Cortés-Penfield has been with our ID group for just under a year now, and is no stranger to digital and social media, having launched his own blog during fellowship, and a new digital journal club “ID Journal Club” hosted on Twitter. He is now joining our blogging group here at UNMC ID and will be a regular contributor. Learn more about him here.

The Weekly Corona with Dr. Raquel Lamarche

Dr. Raquel Lamarche is a PGY1 Internal Medicine/Pediatrics resident at UNMC, who will be summarizing updates about SARS-CoV-2 and hopefully make information easier to digest, with additional outlines of implications for graduate medical education.